http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Medtronic chairman and CEO Geoff Martha to speak at Goldman Sachs global healthcare conference
-
Medtronic (MDT) to acquire EOFlow for ~$738 million
-
Medtronic to acquire wearable insulin patch maker EOFlow
-
Medtronic reports full year and fourth quarter fiscal 2023 financial results; announces dividend increase
-
Medtronic Extravascular ICD global clinical trial results reinforce device safety and effectiveness
-
Medtronic AccuRhythm AI technology receives 2023 MedTech Breakthrough Award as Best New Monitoring Solution
-
Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
-
Medtronic (MDT) receives FDA approval for its next generation Micra leadless pacing systems
-
Medtronic receives FDA approval for its next generation Micra leadless pacing systems
-
Medtronic Diabetes resolves warning letter, clearing path for future innovations
-
Medtronic (MDT) and DaVita (DVA) Launch Mozarc Medical
-
Medtronic, DaVita launch Mozarc Medical, aimed at introducing new solutions for patients with kidney failure
-
Medtronic (MDT) to boost AI innovation with new platform introduction
-
Medtronic to boost AI innovation with new platform introduction
-
Medtronic (MDT) receives CE Mark approval for Affera Mapping and Ablation System to treat atrial arrhythmias
-
Medtronic receives CE Mark approval for Affera™ Mapping and Ablation System to treat atrial arrhythmias
-
Medtronic named one of World's Most Ethical Companies
-
Medtronic (MDT) Reports Strong Results for FDA PulseSelect PFA System in PULSED AF IDE trial
-
Medtronic PulseSelect PFA System demonstrates impressive results in landmark PULSED AF global IDE trial
-
Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2023
-
Medtronic Executive Vice President and CFO Karen Parkhill to speak at Cowen healthcare conference
-
MiniMed™ 780G system demonstrates superiority over multiple daily injections with CGM for type 1 diabetes management at one-year in ADAPT study
-
Medtronic reports third quarter fiscal 2023 financial results
-
Medtronic (MDT) Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
-
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
-
Medtronic to announce financial results for its third quarter of fiscal year 2023
-
Medtronic LINQ Insertable Cardiac Monitor detects 10 times more atrial fibrillation in ischemic stroke patients at three years compared to standard of care
-
Medtronic continues to make significant advances as an Inclusion, Diversity & Equity leader
-
Medtronic recommends rejection of below-market mini-tender offer by TRC Capital Investment Corporation
-
Medtronic named one of America's Most JUST Companies by JUST Capital and CNBC
-
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
-
Medtronic announces first patient enrolled in U.S. clinical trial for Hugo™ robotic-assisted surgery system
-
Medtronic named as a leading sustainability company
-
Medtronic announces cash dividend for third quarter of fiscal year 2023
-
Medtronic completes enrollment in pivotal trial evaluating first-of-its-kind pulsed field ablation catheter for patients with atrial fibrillation
-
Medtronic executives to speak at the Evercore ISI 5th annual HealthCONx conference
-
Medtronic reports second quarter fiscal 2023 financial results
-
Medtronic to announce financial results for its second quarter of fiscal year 2023
-
Medtronic (MDT) Launches World's First and Only Infusion Set for Insulin Pumps
-
Medtronic Launches World's First and Only Infusion Set for Insulin Pumps that Doubles Wear Time up to 7 days in U.S.
-
Cloud DX Announces Consortium to Advance Affordable Hospital-Level Care at Home
-
Medtronic (MDT) Reports 6-month Data from SPYRAL HTN-ON MED Trial
-
SPYRAL HTN-ON MED study demonstrates meaningful clinical benefits consistent with other SPYRAL HTN renal denervation trials
-
Cloud DX Announces 6th Ontario Paramedicine Group Contract
-
Announcing the launch of Medtronic Neurovascular Co-Lab™ Platform to accelerate innovation in stroke treatment
-
Cloud DX and Medioh Create Sustainable and Scalable Remote Monitoring Solutions for US and Canada
-
Medtronic chairman and CEO Geoff Martha to speak at the CECP's CEO Investor Forum
-
Medtronic (MDT) to Spin Off Combined Patient Monitoring and Respiratory Interventions Businesses
-
Medtronic announces intention to separate its combined Patient Monitoring and Respiratory Interventions businesses
-
Medtronic expands global access to the benefits of robotic-assisted surgery

